A Phase III Clinical Trial of Hydroxyflutamide (Liproca Depot) in Prostate Cancer
Phase of Trial: Phase III
Latest Information Update: 07 Nov 2019
Price : $35 *
At a glance
- Drugs Hydroxyflutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 07 Nov 2019 According to a LIDDS media release, this phase III clinical trial will be conducted in urology clinics in China and will be fully financed by the Jiangxi Puheng Pharma.
- 07 Nov 2019 According to a LIDDS media release, LIDDS AB, Jiangxi Puheng Pharma has after reviewing the preliminary results in LPC-004 decided to move ahead and has initiated discussions with Chinese medical authority, CFDA. This phase III study protocol will be developed in close collaboration with LIDDS.
- 06 Mar 2019 According to the LIDDS media release, this study will be fully funded by the Chinese licensee.